Recent scientific advancements have led to the development of a nanotechnology-based cancer drug that is 20,000 times more potent than its predecessors, yet remarkably, it exhibits no detectable side ...

The pharmaceutical industry is a pillar of global health, valued at over $1.5 trillion. Within this sector, Analytical Research and Development (AR&D) ensures drug quality, safety, and efficacy. AR&D ...

MIAMI, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies ...

Beyond the sale of banned, expired, falsified and substandard drugs, PUNCH Healthwise investigations across three major open drug markets in the country, Idumota, Aba and Onitsha, revealed that ...

It also exhibited robust selectivity, sparing FGFR1/4, and showed minimal off-target effects against a broad panel of kinases. In preclinical models, compound 10 displayed favorable pharmacokinetics, ...

Discover the innovative Alco5 platform by Tubulis, advancing cancer therapies with novel antibody-drug conjugate technology.

insitro has acquired Israeli AI therapeutics company CombinAbleAI and launched its TherML platform, creating an end-to-end, ...

By Patrick Wingrove Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the ...

A lab analysis of the lethal injection drug supply Arizona is relying on to resume executions provides no evidence of its efficacy or purity, and it's not clear the state plans to do further testing ...